Table 5.
Other Examples of CNTs Used for the Delivery of Molecules
| CNTs | Molecules | Functional Group | Particle Size | Release Control | In vitro/in vivo | Ref. |
|---|---|---|---|---|---|---|
| SWCNTs | Carnosine dipeptide | Modified with PEG at the lysine residues via amide bonds | – | – | – | [172] |
| SWNTs | DOX | Modified with oxidative acid and PEG-g-PEI | Diameter 1–2 nm, length 1–3 nm, SSA 380 m2/g | Acidic pH | In vitro | [173] |
| MWCNTs | DOX | Functionalized with (TAT)-chitosan (MWCNTs-TC) | – | – | In vivo, in vitro | [174] |
| SWCNT | DTX | Functionalized with iron oxide NPs and coated by PLA co-mPEG micelles | ~ 15–50nm | External magnetic fields | In vivo, in vitro | [175] |
| SWCNT | EGFP (nEGFP) | Functionalized with streptavidin | ~ 200 nm in length | Light-responsive | In vivo, in vitro | [176] |
| MWCNT | Zolpidem (ZM) | Modified with D-glucose (Gl) | Diameter of MWCNTCOOH 10 nm, 27 nm in MWCNT-Gl | - | In vitro | [177] |
| SWNTs | DOX | Non-covalently functionalized with PL-PEG | ~ 1 nm and ~1.2 nm inner and outer diameters, 50–200 nm PEG-coated SWNTs | NIR irradiation | In vitro | [178] |
| MWCNT | DTX | Chitosan-folate (CHI-FA) conjugated MWCNT | ~ 230 to 483 nm in length | – | In vivo, in vitro | [179] |
| MWCNTs | Antigenic protein (OVA) | Modified with lentinan | 9–10 nm in diameter, 1–2 μm in length | – | In vivo, in vitro | [180] |